InvestSMART

Origin Energy Limited (ASX:ORG)

ALERT: Price-sensitive ASX Announcement for ORG
Current share price for ORG : $10.895 -0.785 (-6.72%)+
Announcement
Release
31 Jul 2025 8:29AM
Price at Release
$11.680
Full Release
download
Summary
The June 2025 Quarterly Report for Origin Energy Limited highlights various aspects of their operations, particularly focusing on their Integrated Gas and Energy Markets. The report shows a decrease in LNG production by 2% compared to the previous year, with total production reaching 682.1 PJ. LNG sales, however, experienced a slight increase due to higher purchases and agreements such as the one with QCLNG, despite a decline in production performance in fields like Condabri, Talinga, and Orana. The document elaborates on the financial performance, noting a decrease in commodity revenue from domestic gas sales by 15%, although LNG commodity revenue saw a modest growth. The report also discusses capital expenditures and future guidance, maintaining a stable strategic outlook for APLNG, Origin's significant joint venture. Average realised prices for LNG decreased and the exchange rates varied slightly, impacting revenue and expenses. Overall, the report indicates a challenging year with a focus on strategic agreements to mitigate production shortfalls.
Key Points
  • LNG production decreased by 2% compared to the previous year, totaling 682.1 PJ.
  • Sales volumes were bolstered by agreements like the QCLNG gas purchase, despite production declines.
  • Commodity revenue from domestic gas decreased by 15%, while LNG revenue showed slight growth.
  • Strategic focus remains on APLNG, with ongoing capital expenditures and a stable strategic outlook.
  • Average realised LNG prices and fluctuating exchange rates impacted financial performance.
  • Production declines were partly due to underperformance and maintenance in certain fields.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.